In recognition of the safety and efficacy of buprenorphine pharmacotherapy, the Victorian Department of Health's Policy for Maintenance Pharmacotherapy for Opioid Dependence was amended in April 2021 to allow all medical practitioners to prescribe selected buprenorphine formulations for up to 10 patients without undertaking the formal RACGP pharmacotherapy training. This is an important change to improve patient access to pharmacotherapy.
The formulations which any general practitioner may prescribe are:
The Brief clinical guidelines for long-acting injectable buprenorphine (downloads as Word doc) were updated in 2021 and are available at the Department of Health Pharmacotherapy hub.
An even more concise primer for buprenorphine prescribing can be found in this six-page guide which outlines the step-by-step process for prescribing sublingual buprenorphine.
Access the free MATOD modules described below.
The Area 4 Pharmacotherapy Network offers a variety of supports for GPs managing patients with opioid dependence:
Contact the Area 4 Pharmacotherapy Network to access any of these free supports.
South Eastern Melbourne PHN
Contact Us
Site usage
While the Australian Government Department of Health has contributed to the funding of this website, the information on this website does not necessarily reflect the views of the Australian Government and is not advice that is provided, or information that is endorsed, by the Australian Government. The Australian Government is not responsible in negligence or otherwise for any injury, loss or damage however arising from the use of or reliance on the information provided on this website.
SEMPHN acknowledges the Bunurong and Wurundjeri peoples of the Kulin Nation, the Traditional Owners and Custodians of the lands, waters, and skies in which we work. We pay our respects to their Elders past and present. We also acknowledge all First Nations peoples with whom we work. Sovereignty was never ceded!